E-Learning

(Bloomberg) -- A weaker dollar will improve the earnings outlook for US stocks, potentially turning around the massive rotation that’s been underway in global markets since start of the year, according to Morgan Stanley strategists including Michael Wilson.Most Read from BloombergThey Built a Secret Apartment in a Mall. Now the Mall Is Dying.Chicago Transit Faces ‘Doomsday Scenario,’ Regional Agency SaysLA Faces $1 Billion Budget Hole, Warns of Thousands of LayoffsNew York Subway Ditches MetroCa

(Bloomberg) -- Indonesian stocks trimmed losses after the country’s new sovereign wealth fund said two former presidents will be advisors, easing market concerns over its leadership.Most Read from BloombergThey Built a Secret Apartment in a Mall. Now the Mall Is Dying.Chicago Transit Faces ‘Doomsday Scenario,’ Regional Agency SaysLA Faces $1 Billion Budget Hole, Warns of Thousands of LayoffsNew York Subway Ditches MetroCard After 32 Years for Tap-And-GoLibraries Warn They Could Be ‘Cut off at th

Alta’s stock price has taken a beating over the past six months, shedding 20.9% of its value and falling to $5.10 per share. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

Over the past six months, DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 8% to $74.17 per share. This run-up might have investors contemplating their next move.

Over the last six months, Alight’s shares have sunk to $6.25, producing a disappointing 13.9% loss while the S&P 500 was flat. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

Peloton has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 38.7% and now trades at $7.17. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Amdocs has been treading water for the past six months, recording a small return of 3.2% while holding steady at $89.48.

What a fantastic six months it’s been for Zevia. Shares of the company have skyrocketed 95.3%, hitting $2.09. This run-up might have investors contemplating their next move.

Over the past six months, IDEX’s shares (currently trading at $184.50) have posted a disappointing 13.2% loss while the S&P 500 was flat. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.

UniFirst currently trades at $198 per share and has shown little upside over the past six months, posting a middling return of 4.4%.